DaVita (DVA) Competitors

DaVita (NYSE:DVA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Is DVA or FMS more profitable?

DaVita has a net margin of 6.61% compared to Fresenius Medical Care's net margin of 2.48%. DaVita's return on equity of 68.52% beat Fresenius Medical Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.61%	68.52%	4.98%
Fresenius Medical Care	2.48%	5.29%	2.30%

Which has higher valuation and earnings, DVA or FMS?

DaVita has higher earnings, but lower revenue than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$12.14B	1.00	$691.53M	$8.80	15.74
Fresenius Medical Care	$21.05B	0.59	$540.07M	$0.89	23.88

Which has more risk and volatility, DVA or FMS?

DaVita has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.

Do analysts recommend DVA or FMS?

DaVita presently has a consensus target price of $144.67, suggesting a potential upside of 4.42%. Fresenius Medical Care has a consensus target price of $24.00, suggesting a potential upside of 12.94%. Given Fresenius Medical Care's higher probable upside, analysts plainly believe Fresenius Medical Care is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Fresenius Medical Care	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Do insiders and institutionals hold more shares of DVA or FMS?

90.1% of DaVita shares are owned by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are owned by institutional investors. 2.0% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer DVA or FMS?

DaVita received 87 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.70% of users gave DaVita an outperform vote while only 53.99% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
DaVita	Outperform Votes 493 61.70%	Underperform Votes 306 38.30%
Fresenius Medical Care	Outperform Votes 406 53.99%	Underperform Votes 346 46.01%

Does the media refer more to DVA or FMS?

In the previous week, DaVita had 3 more articles in the media than Fresenius Medical Care. MarketBeat recorded 8 mentions for DaVita and 5 mentions for Fresenius Medical Care. DaVita's average media sentiment score of 1.21 beat Fresenius Medical Care's score of 0.91 indicating that DaVita is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

DaVita beats Fresenius Medical Care on 14 of the 18 factors compared between the two stocks.